# üõ°Ô∏è Cancer Fund Flow Monitor: International Audit Terminal (v2.0.0)

> **Closing the "Memory Hole" of administrative silence in global oncology healthcare.**

## üè• Mission
This project leverages the **AO Network** and **Arweave** to provide a permanent, decentralized audit layer for cancer drug reimbursement data. Our goal is to expose systemic inefficiencies and ensure that life-saving transparency is never erased by bureaucracy.

## üìä The "7.6x Efficiency Gap"
As a professional in the chemotherapy drug industry, I have identified a critical delay in patient care that often remains hidden from public scrutiny:

| Metric | üáπüáº Taiwan (NHIA) | üáØüáµ Japan (MHLW) | Disparity |
| :--- | :--- | :--- | :--- |
| **Reimbursement Lag** | **458 Days** | **60-90 Days** | **7.6x Slower** |
| **Administrative Fee** | **150,000 TWD** | Standardized | High Friction |

### üìä The Cost of Administrative Silence: Japan vs. Taiwan

To demonstrate the power of the **AO Truth Machine**, we audited the reimbursement gap for critical oncology drugs. 

üö® Extreme Audit Discovery: > Our system identified that Tecentriq faced an administrative silence of 2,875 Days (~8 Years) in Taiwan. This is the ultimate "Memory Hole" we are sealing with AO.

| Drug Name | Japan (MHLW) | Taiwan (NHIA) | The "Silence" Gap |
| :--- | :--- | :--- | :--- |
| **Tagrisso** | 58 Days | 1,225 Days | **21x Slower** |
| **Enhertu** | 60 Days | 458 Days | **7.6x Slower** |
| **Tecentriq**| Standardized | **2,875 Days** | **~8 Years of Silence** |

> "The wait for Tecentriq (8 years) isn't just a delay; it's an erasure of patient rights. We use AO to make sure these 'Memory Holes' are sealed forever."

"The wait for Colorectal cancer (Keytruda) costs a family 7.6 million TWD in self-pay drugs. This isn't healthcare; it's a financial death sentence."

**Financial Impact on Patients:**
In Taiwan, patients pay approximately **150,000 TWD ($4,600 USD) per month** during this wait. 
- Total "Administrative Delay" cost: **~5,835,000 TWD per patient.**
- This is the **"Survival Barrier"** that our AO project aims to record and expose forever.
*Data based on real-world monitoring of drugs like **Tagrisso** and systemic administrative silos.*

## üöÄ Live on Permaweb
The terminal is deployed as a permanent application on Arweave:
üîó **[Live Audit Terminal](https://arweave.net/knzlINWz3U8KT5Y8afivO38ao6v5ctqNjty0rg_1YZY)**

üöÄ What's New in v2.0.0 (Technical Migration)
This update marks the transition from a data model to a decentralized, autonomous audit protocol.

AOS Process Architecture: Core audit logic has been migrated to AOS processes (OncoAudit.lua & monitor.lua), enabling high-concurrency, cross-border data verification.

International Benchmarking: Integrated Japan‚Äôs MHLW data to programmatically calculate the 7.6x efficiency gap.

Proof of Permanence: Established the protocol to seal government records on Arweave. We are currently preparing to archive the 2,875-day Tecentriq records, pending the 10GB storage endowment for lifelong integrity.

üõ†Ô∏è Technical Architecture & Roadmap (v3.0)We are evolving into a fully Autonomous Monitoring Engine.Current Tech Stack:AO Network: Parallel compute for multi-source fund flow verification.Arweave: Cryptographically sealing reports to prevent "Memory Holes".AOS (Lua): Handling complex pharmaceutical data schemas.Next Steps (The Pathfinder Path):[v3.0 Target] AO Cron Jobs: Implementing 24/7 autonomous polling of regulatory APIs without human intervention.[Resource Allocation] AOS Scaling: Utilizing the $\$10,000$ development grant to recruit specialized AOS (Lua) engineers to build the multi-jurisdiction data normalization engine (Target: Japan MHLW vs. Taiwan NHIA).[Infrastructure] Compute Credits: Leveraging the $\$5,000$ compute credits to run high-frequency audit agents on AO.

## üìÖ Roadmap
- [x] **v1.0.0**: Local pilot for Taiwan drug fund tracking.
- [x] **v2.0.0**: International benchmarking (Japan) and English UI deployment.
- [ ] **v3.0**: Automated data ingestion via AO Crons & Multi-country expansion.
- [ ] **v4.0**: Full-scale high-value drug coverage and DAO-powered global healthcare justice protocol.

---
*Built with passion by a builder who believes that data can save lives.*
